Literature DB >> 29542684

Exosomes from Suxiao Jiuxin pill-treated cardiac mesenchymal stem cells decrease H3K27 demethylase UTX expression in mouse cardiomyocytes in vitro.

Xiao-Fen Ruan1,2, Yong-Jun Li3,2, Cheng-Wei Ju3,2, Yan Shen2, Wei Lei4, Can Chen4, Yang Li2, Hong Yu5, Yu-Tao Liu2, Il-Man Kim2, Xiao-Long Wang1, Neal L Weintraub2, Yaoliang Tang2.   

Abstract

Suxiao Jiuxin pill (SJP) is a traditional Chinese medicine for the treatment of acute coronary syndrome in China, which contains two principal components, tetramethylpyrazine (TMP) and borneol (BOR). Thus far, however, the molecular mechanisms underlying the beneficial effects of SJP on the cardiac microenvironment are unknown. Cardiac mesenchymal stem cells (C-MSCs) communicate with cardiomyocytes (CMs) through the release of microvesicles (exosomes) to restore cardiac homeostasis and elicit repair, in part through epigenetic regulatory mechanisms. In this study, we examined whether SJP treatment altered C-MSC-derived exosomes (SJP-Exos) to cause epigenetic chromatic remodeling in recipient CMs. C-MSC isolated from mouse hearts were pretreated with SJP (SJP-Exos), TMP (TMP-Exos) or BOR (BOR-Exos). Then, HL-1 cells, a mouse cardiomyocyte line, were treated with exosomes from control C-MSCs (Ctrl-Exos), SJP-Exos, TMP-Exos or BOR-Exos. Treatment with SJP-Exos significantly increased the protein levels of histone 3 lysine 27 trimethylation (H3K27me3), a key epigenetic chromatin marker for cardiac transcriptional suppression, in the HL-1 cells. To further explore the mechanisms of SJP-Exo-mediated H3K27me3 upregulation, we assessed the mRNA expression levels of key histone methylases (EZH1, EZH2 and EED) and demethylases (JMJD3 and UTX) in the exosome-treated HL-1 cells. Treatment with SJP-Exo selectively suppressed UTX expression in the recipient HL-1 cells. Furthermore, PCNA, an endogenous marker of cell replication, was significantly higher in SJP-Exo-treated HL-1 cells than in Ctrl-Exo-treated HL-1 cells. These results show that SJP-Exos increase cardiomyocyte proliferation and demonstrate that SJP can modulate C-MSC-derived exosomes to cause epigenetic chromatin remodeling in recipient cardiomyocytes; consequently, SJP-Exos might be used to promote cardiomyocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29542684      PMCID: PMC5888694          DOI: 10.1038/aps.2018.18

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  34 in total

Review 1.  Boosters and barriers for direct cardiac reprogramming.

Authors:  Mahmood Talkhabi; Elmira Rezaei Zonooz; Hossein Baharvand
Journal:  Life Sci       Date:  2017-04-18       Impact factor: 5.037

2.  Polycomb repressive complex 2 regulates normal development of the mouse heart.

Authors:  Aibin He; Qing Ma; Jingjing Cao; Alexander von Gise; Pingzhu Zhou; Huafeng Xie; Bing Zhang; Michael Hsing; Danos C Christodoulou; Patrick Cahan; George Q Daley; Sek Won Kong; Stuart H Orkin; Christine E Seidman; Jonathan G Seidman; William T Pu
Journal:  Circ Res       Date:  2011-12-08       Impact factor: 17.367

3.  Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo.

Authors:  Sophie Dal-Pra; Conrad P Hodgkinson; Maria Mirotsou; Imke Kirste; Victor J Dzau
Journal:  Circ Res       Date:  2017-02-16       Impact factor: 17.367

4.  Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium.

Authors:  Yao Liang Tang; Qiang Zhao; Y Clare Zhang; Leilei Cheng; Mingya Liu; Jianhui Shi; Yin Zeng Yang; Chuizhen Pan; Junbo Ge; M Ian Phillips
Journal:  Regul Pept       Date:  2004-01-15

5.  [Effects of suxiao jiuxin pill on patients with acute coronary syndrome undergoing early percutaneous coronary intervention].

Authors:  Xiao-Long Wang; Yong-Ming Liu; Gu-Jing Zhu
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2012-11

6.  Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression.

Authors:  Yao Liang Tang; Wuqiang Zhu; Min Cheng; Lijuan Chen; John Zhang; Tao Sun; Raj Kishore; M Ian Phillips; Douglas W Losordo; Gangjian Qin
Journal:  Circ Res       Date:  2009-04-30       Impact factor: 17.367

7.  Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.

Authors:  Changjin Lee; S Alex Mitsialis; Muhammad Aslam; Sally H Vitali; Eleni Vergadi; Georgios Konstantinou; Konstantinos Sdrimas; Angeles Fernandez-Gonzalez; Stella Kourembanas
Journal:  Circulation       Date:  2012-10-31       Impact factor: 29.690

8.  Conditional ablation of Ezh2 in murine hearts reveals its essential roles in endocardial cushion formation, cardiomyocyte proliferation and survival.

Authors:  Li Chen; Yanlin Ma; Eun Young Kim; Wei Yu; Robert J Schwartz; Ling Qian; Jun Wang
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

9.  Infrared fluorescent protein 1.4 genetic labeling tracks engrafted cardiac progenitor cells in mouse ischemic hearts.

Authors:  Lijuan Chen; M Ian Phillips; Hui-Lai Miao; Rong Zeng; Gangjian Qin; Il-man Kim; Neal L Weintraub; Yaoliang Tang
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

10.  Assessing in vitro stem-cell function and tracking engraftment of stem cells in ischaemic hearts by using novel iRFP gene labelling.

Authors:  Yingjie Wang; Mi Zhou; Xiaolong Wang; Gangjian Qin; Neal L Weintraub; Yaoliang Tang
Journal:  J Cell Mol Med       Date:  2014-06-09       Impact factor: 5.310

View more
  18 in total

1.  Extracellular vesicles as novel biomarkers and pharmaceutic targets of diseases.

Authors:  Yanfang Chen; Yaoliang Tang; Guo-Chang Fan; Dayue Darrel Duan
Journal:  Acta Pharmacol Sin       Date:  2018-04       Impact factor: 6.150

2.  Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice.

Authors:  Xuan Su; Yan Shen; Yue Jin; Meng Jiang; Neal Weintraub; Yaoliang Tang
Journal:  J Vis Exp       Date:  2019-04-10       Impact factor: 1.355

Review 3.  A New Era of Cardiac Cell Therapy: Opportunities and Challenges.

Authors:  Ke Huang; Shiqi Hu; Ke Cheng
Journal:  Adv Healthc Mater       Date:  2018-12-13       Impact factor: 9.933

Review 4.  New Approaches for Enhancement of the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Diseases.

Authors:  Lamiaa Ahmed; Khaled Al-Massri
Journal:  Tissue Eng Regen Med       Date:  2022-07-22       Impact factor: 4.451

5.  Isolation of Swine Bone Marrow Lin-/CD45-/CD133 + Cells and Cardio-protective Effects of its Exosomes.

Authors:  Hongxiao Li; Jianjun Gu; Xiaolin Sun; Qisheng Zuo; Bichun Li; Xiang Gu
Journal:  Stem Cell Rev Rep       Date:  2022-08-04       Impact factor: 6.692

6.  Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes for Angiogenesis.

Authors:  Chengwei Ju; Youngjun Li; Yan Shen; Yutao Liu; Jingwen Cai; Naifeng Liu; Gengshan Ma; Yaoliang Tang
Journal:  J Cardiovasc Transl Res       Date:  2018-10-01       Impact factor: 4.132

7.  Exosome-Derived Dystrophin from Allograft Myogenic Progenitors Improves Cardiac Function in Duchenne Muscular Dystrophic Mice.

Authors:  Xuan Su; Yue Jin; Yan Shen; Chengwei Ju; Jingwen Cai; Yutao Liu; Il-Man Kim; Yu Wang; Hong Yu; Neal L Weintraub; Meng Jiang; Yaoliang Tang
Journal:  J Cardiovasc Transl Res       Date:  2018-08-28       Impact factor: 4.132

8.  Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes Promotes Repair in Ischemic Myocardium.

Authors:  Chengwei Ju; Yan Shen; Gengshan Ma; Yutao Liu; Jingwen Cai; Il-Man Kim; Neal L Weintraub; Naifeng Liu; Yaoliang Tang
Journal:  J Cardiovasc Transl Res       Date:  2018-09-19       Impact factor: 4.132

9.  Identification of critical molecular pathways involved in exosome-mediated improvement of cardiac function in a mouse model of muscular dystrophy.

Authors:  Xuan Su; Yan Shen; Yue Jin; Neal L Weintraub; Yao-Liang Tang
Journal:  Acta Pharmacol Sin       Date:  2020-06-29       Impact factor: 6.150

Review 10.  Biomimetic and immunomodulatory therapeutics as an alternative to natural exosomes for vascular and cardiac applications.

Authors:  Ramiro A Villarreal-Leal; John P Cooke; Bruna Corradetti
Journal:  Nanomedicine       Date:  2021-03-24       Impact factor: 6.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.